We catalyze and fund the advancement of new therapies and interventions to detect, treat, and prevent Alzheimer's disease, related dementias, and cognitive impairment associated with aging. To accomplish this, the ADDF and the ISOA funds scientific research programs in academia and in biotechnology companies, worldwide.

In addition, the ADDF and ISOA initiates, sponsors, and co-sponsors conferences to stimulate new ideas and approaches in areas of interest to the Foundation, bringing together outstanding physicians, scientists, and policy makers from around the world.